Cross-sectional survey links hepatitis B treatment burden to stopping thoughts
A cross-sectional survey links peginterferon adverse-effect burden and psychological distress with thoughts of stopping chronic hepatitis B treatment, while treatment ...
A cross-sectional survey links peginterferon adverse-effect burden and psychological distress with thoughts of stopping chronic hepatitis B treatment, while treatment ...
A small observational study found that serum CXCL-10 and CTLA-4 were associated with HBV viral load and histological inflammation in ...
A retrospective single-center study of 382 chronic hepatitis B patients found that the internally validated HEP-FIB score outperformed APRI, FIB-4 ...
Researchers fused the preS1 regions of hepatitis B virus genotypes B and C into a single recombinant antigen, enabling an ...
Researchers found that reduced methylation of the CXCL16 gene promoter in chronic hepatitis B patients tracks with elevated chemokine expression ...
An investigational epigenetic silencer therapy reported in Nature Biomedical Engineering aims to transcriptionally inactivate hepatitis B viral DNA by locking ...
A new review in Virology Journal explains how cccDNA persistence, viral genome integration and multi-level immune exhaustion keep functional cure ...
A large prospective Chinese cohort study finds that sustained HBsAg seroclearance with very low HBV DNA is associated with lower ...
A new review argues that programmable epigenetic editors could functionally cure chronic hepatitis B by durably silencing viral cccDNA and ...
Researchers have identified ANKRD11 as a chromatin regulator whose loss reprograms CD8+ T cells to fight chronic hepatitis B and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine